Hong Jae Chon (Hong-Jae Chon)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 36

Top Topics

Metastatic Colorectal Cancer

Renal Cell Carcinoma

Top Venues

Annals of hepato-biliary-pancreatic surgery

Journal for immunotherapy of cancer

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yun Beom Sang, Chaeryoung Lee, Seul-Gi Kim, Boyoung Lee, Beodeul Kang, Joo Hoon Kim, Hong Jae Chon
Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab. Journal of clinical medicine 13 (5) (2024)
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bo Hyun Kim, Seong Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji-Hae Nahm, Won Suk Park, Eun Kyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang-Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoung-Bun Lee, Dong Ho Lee, Myung Ah Lee, Seung-Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Eun Yong Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon-Seong Park
Practice guidelines for managing extrahepatic biliary tract cancers. Annals of hepato-biliary-pancreatic surgery 28 (2) (2024)
Jung Sun Kim, Hong Jae Chon
Exploring treatment options for biliary tract cancers: moving beyond the era of gemcitabine and platinum doublet. Hepatobiliary surgery and nutrition 13 (3) (2024)
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bo Hyun Kim, Seong Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji-Hae Nahm, Won Suk Park, Eun Kyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang-Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoung-Bun Lee, Dong Ho Lee, Myung Ah Lee, Seung-Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Eun Yong Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon-Seong Park
Practice guidelines for managing extrahepatic biliary tract cancers. Annals of hepato-biliary-pancreatic surgery 28 (2) (2024)
Jung Sun Kim, Hong Jae Chon
Exploring treatment options for biliary tract cancers: moving beyond the era of gemcitabine and platinum doublet. Hepatobiliary surgery and nutrition 13 (3) (2024)
Jaekyung Cheon, Sang-Hoon Jung, Jung Sun Kim, Beodeul Kang, Hyeyoung Kim, Landon L Chan, Lars Becker, Vincent E Gaillard, Stephen L Chan, Chan Kim, Hong Jae Chon
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Jaekyung Cheon, Sang-Hoon Jung, Jung Sun Kim, Beodeul Kang, Hyeyoung Kim, Landon L Chan, Lars Becker, Vincent E Gaillard, Stephen L Chan, Chan Kim, Hong Jae Chon
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bo Hyun Kim, Seong Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji-Hae Nahm, Won Suk Park, Eun Kyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang-Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoung-Bun Lee, Dong Ho Lee, Myung Ah Lee, Seung-Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Eun Yong Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon-Seong Park
Practice guidelines for managing extrahepatic biliary tract cancers. Annals of hepato-biliary-pancreatic surgery 28 (2) (2024)
Hyung Sun Kim, Mee Joo Kang, Jingu Kang, Kyubo Kim, Bo Hyun Kim, Seong Hun Kim, Soo Jin Kim, Yong-Il Kim, Joo Young Kim, Jin Sil Kim, Haeryoung Kim, Hyo Jung Kim, Ji-Hae Nahm, Won Suk Park, Eun Kyu Park, Joo Kyung Park, Jin Myung Park, Byeong Jun Song, Yong Chan Shin, Keun Soo Ahn, Sang-Myung Woo, Jeong Il Yu, Changhoon Yoo, Kyoung-Bun Lee, Dong Ho Lee, Myung Ah Lee, Seung-Eun Lee, Ik Jae Lee, Huisong Lee, Jung Ho Im, Kee-Taek Jang, Hye Young Jang, Sun-Young Jun, Hong Jae Chon, Min Kyu Jung, Eun Yong Chung, Jae Uk Chong, Eunae Cho, Eui Kyu Chie, Sae Byeol Choi, Seo-Yeon Choi, Seong Ji Choi, Joon Young Choi, Hye-Jeong Choi, Seung-Mo Hong, Ji Hyung Hong, Tae Ho Hong, Shin Hye Hwang, In Gyu Hwang, Joon-Seong Park
Practice guidelines for managing extrahepatic biliary tract cancers. Annals of hepato-biliary-pancreatic surgery (2024)
Yun Beom Sang, Chaeryoung Lee, Seul-Gi Kim, Boyoung Lee, Beodeul Kang, Joo Hoon Kim, Hong Jae Chon
Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab. Journal of clinical medicine 13 (5) (2024)
Jaekyung Cheon, Hyeyeong Kim, Han Sang Kim, Chang Gon Kim, Ilhwan Kim, Beodeul Kang, Chan Kim, Sanghoon Jung, Yeonjung Ha, Hong Jae Chon
Atezolizumab plus bevacizumab in patients with child-Pugh B advanced hepatocellular carcinoma. Therapeutic advances in medical oncology 15 (2023)
Eun-Jin Go, Hannah Yang, Wooram Park, Seung Joon Lee, Jun-Hyeok Han, So Jung Kong, Won Suk Lee, Dong Keun Han, Hong Jae Chon, Joo Hoon Kim
Systemic Delivery of a STING Agonist-Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis. Small (Weinheim an der Bergstrasse, Germany) (2023)
Eun-Jin Go, Hannah Yang, Seung Joon Lee, Hyun Gul Yang, Jin A Shin, Won Suk Lee, Hye Seong Lim, Hong Jae Chon, Joo Hoon Kim
PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis. Oncoimmunology 12 (1) (2023)
Hyehyun Jeong, Kyu-Pyo Kim, Jae Ho Jung, Dae Wook Hwang, Jae-Hoon Lee, Ki Hun Kim, Deok Bog Moon, Myung Ah Lee, Se Jun Park, Hong Jae Chon, Jin-Hong Park, Ji Sung Lee, Baek-Yeol Ryoo, Changhoon Yoo
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial. Hepatology (Baltimore, Md.) 77 (5) (2023)
Young Eun Chon, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do Young Kim, Seong Gyu Hwang, Hong Jae Chon, Beom Kyung Kim
Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment. Cancer medicine (2022)
Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon, Joo Hoon Kim
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma. Cancers 14 (23) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Won Suk Lee, Dong Sung Kim, Jeong Hun Kim, Yoonki Heo, Hannah Yang, Eun-Jin Go, Jin Hyoung Kim, Seung Joon Lee, Byung Cheol Ahn, Jung Sun Yum, Hong Jae Chon, Joo Hoon Kim
Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade. Journal for immunotherapy of cancer 10 (6) (2022)
Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon, Joo Hoon Kim
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma. Cancers 14 (23) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon, Joo Hoon Kim
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma. Cancers 14 (23) (2022)
Han Sang Kim, Chang Gon Kim, Jung Yong Hong, Il-Hwan Kim, Beodeul Kang, Sanghoon Jung, Chan Kim, Sang Joon Shin, Hye Jin Choi, Jaekyung Cheon, Hong Jae Chon, Ho Yeong Lim
The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma. Therapeutic advances in medical oncology 14 (2022)
Seung Joon Lee, Hannah Yang, Woo Ram Kim, Yu Seong Lee, Won Suk Lee, So Jung Kong, Hye Jin Lee, Jeong Hun Kim, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Joo Hoon Kim
STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer. Journal for immunotherapy of cancer 9 (6) (2022)
Ji Yoon Jung, Hong Jae Chon, Young Jin Choi, Sang Eun Yeon, Seok Young Choi, Kyung Hee Lee
A prospective, multicenter, open-label study of the clinical efficacy of tapentadol extended-release in the treatment of cancer-related pain and improvement in the quality of life of opioid-naïve or opioid-resistant patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (7) (2022)
Yun Beom Sang, Gwangil Kim, Sohyun Hwang, Haeyoun Kang, Hong Jae Chon
Dramatic Response to Cabozantinib in a Patient with Refractory Hepatocellular Carcinoma with c- MET Amplification. Journal of clinical and translational hepatology 11 (3) (2022)
Yun Beom Sang, Gwangil Kim, Sohyun Hwang, Haeyoun Kang, Hong Jae Chon
Dramatic Response to Cabozantinib in a Patient with Refractory Hepatocellular Carcinoma with c- MET Amplification. Journal of clinical and translational hepatology 11 (3) (2022)
Beom Kyung Kim, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do Young Kim, Seong Gyu Hwang, Young Eun Chon, Hong Jae Chon
Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study. Cancers 14 (7) (2022)
Choong-Kun Lee, Stephen L Chan, Hong Jae Chon
Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma? Cancers 14 (13) (2022)
Yeong Hak Bang, Choong-Kun Lee, Changhoon Yoo, Hong Jae Chon, Moonki Hong, Beodeul Kang, Hyung-Don Kim, Sook Ryun Park, Won-Mook Choi, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Min-Hee Ryu, Baek-Yeol Ryoo
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis. Therapeutic advances in medical oncology 14 (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Hyung Soon Park, Yoo Min Kim, Sewha Kim, Won Suk Lee, So Jung Kong, Hannah Yang, Beodeul Kang, Jaekyung Cheon, Su-Jin Shin, Joo Hoon Kim, Hong Jae Chon
High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer. Journal for immunotherapy of cancer 9 (10) (2022)
Chang-Gon Kim, Yun Beom Sang, Ji-Hyun Lee, Hong Jae Chon
Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach. International journal of molecular sciences 22 (15) (2021)
Yu Seong Lee, Won Suk Lee, Chang Woo Kim, Seung Joon Lee, Hannah Yang, So Jung Kong, John Ning, Kyung-Mee Yang, Beodeul Kang, Woo Ram Kim, Hong Jae Chon, Joo Hoon Kim
Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer. Journal for immunotherapy of cancer 8 (2) (2021)
Chang Woo Kim, Hong Jae Chon, Joo Hoon Kim
Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer. Cancers 13 (19) (2021)
Ho Jung An, Hong Jae Chon, Joo Hoon Kim
Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors. International journal of molecular sciences 22 (17) (2021)